Abbott Laboratories dividend and valuation
Valuation
Abbott Laboratories paid $2.52 per share in dividends over the last 12 months (yield 2.3%). Last ex-dividend date: October 15, 2026. The P/E ratio is 40.5. The average price target of 26 analysts is $118.91.
Data as of November 16, 2026
Abbott Laboratories compared with similar companies
Abbott Laboratories's P/E (trailing 12 months): 40.5, +29% against the median of a group of 11 similar companies (31.4).
| Metric | Abbott Laboratories | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 40.5 | 31.4 | 25.1 – 36.7 | High |
| Forward P/E | 18.3 | 19.0 | 15.6 – 23.9 | Middle |
| EV/EBITDA | 18.8 | 16.2 | 14.1 – 19.6 | Middle |
| Price/book | 3.68 | 3.68 | 2.93 – 6.19 | Middle |
| Price/sales | 3.90 | 3.90 | 3.18 – 5.29 | Middle |
| Gross margin | 57.2% | 65.7% | 60.3% – 68.7% | Low |
| Operating margin | 15.6% | 19.2% | 16.2% – 22.0% | Low |
| Net margin | 9.7% | 13.4% | 10.0% – 14.6% | Low |
| ROE | 9.1% | 11.6% | 10.0% – 18.0% | Low |
| Debt/equity | 0.61 | 0.55 | 0.37 – 0.63 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Abbott Laboratories: valuation over time
On the latest fiscal year's earnings (2025), Abbott Laboratories's P/E today is 29.2, below the median of its last 10 fiscal years (38.3; between 14.8 and 211.4 from 2016 to 2025). Relative to earnings, the stock costs less than it used to. The dividend yield (2.3%) is above the median of the last 10 fiscal years (1.8%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| 2025 | $125.29 | $3.72 | 33.7 | $2.40 | 1.9% |
| 2024 | $113.11 | $7.64 | 14.8 | $2.24 | 2.0% |
| 2023 | $110.07 | $3.26 | 33.8 | $2.08 | 1.9% |
| 2022 | $109.79 | $3.91 | 28.1 | $1.92 | 1.7% |
| 2021 | $140.74 | $3.94 | 35.7 | $1.82 | 1.3% |
| 2020 | $109.49 | $2.50 | 43.8 | $1.53 | 1.4% |
| 2019 | $86.86 | $2.06 | 42.2 | $1.32 | 1.5% |
| 2018 | $72.33 | $1.33 | 54.4 | $1.16 | 1.6% |
| 2017 | $57.07 | $0.27 | 211.4 | $1.08 | 1.9% |
| 2016 | $38.41 | $0.94 | 40.9 | $1.05 | 2.7% |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- $187.95B
- Enterprise value
- $215.69B
- PEG
- 1.55
- EV/revenue
- 4.47
Profitability and growth
- ROA
- 4.9%
- ROIC
- 6.9%
- Revenue growth (year over year)
- 14.5%
- Earnings growth (year over year)
- -43.6%
Financial health
- Total cash
- $4.3B
- Total debt
- $31.44B
- Current ratio
- 1.46
- Quick ratio
- 0.83
- Altman Z-Score
- 3.41
- Piotroski F-Score
- 5.00
Dividends
- Annual dividend per share
- $2.52
- Dividend yield
- 2.3%
- Payout ratio
- 94.0%
- Ex-dividend date
- October 15, 2026
Analysts and estimates
- Average price target
- $118.91
- Median price target
- $120.00
- High price target
- $130.00
- Low price target
- $100.00
- Analysts with a price target
- 26
- Consensus
- Buy
- Forward EPS
- $5.94
- EPS estimate, current year
- $5.52
Shares and trading
- Beta
- 0.54
- Average volume
- 9M
- Shares outstanding
- 1.73B
- Float
- 1.72B
- Institutional ownership
- 83.4%
- Insider ownership
- 0.8%
- Short interest (% of float)
- 1.2%
- Short ratio (days)
- 1.95
